Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neurons

Brain Research

Volumn 1312, Issue , 2010, Pages 108-119

  Böttger, Danny ^a   Ullrich, Celine ^a   Humpel, Christian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alzheimer; Nerve growth factor; Neuroprotection; NGF secreting monocyte; Transmigration

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; BIOLOGICAL MARKER; CD68 ANTIGEN; CHOLINE ACETYLTRANSFERASE; F ACTIN; FLUORESCEIN; RECOMBINANT NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY; CELL ADHESION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL SECRETION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MEYNERT BASAL NUCLEUS; MONOCYTE; MONOLAYER CULTURE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCEIN; INDOLES; MONOCYTES; NERVE DEGENERATION; NERVE GROWTH FACTOR; ORGAN CULTURE TECHNIQUES; ORGANIC CHEMICALS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

RATTUS;

EID: 73649085769     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.11.062     Document Type: Article

References (58)

1. Begley D.J. Understanding and circumventing the blood-brain barrier. Acta Paediatr. 443 (2003) 83-91
2. Capsoni S., Covaceuszach S., Ugolini G., Spirito F., Vignone D., Stefanini B., Amato G., and Cattaneo A. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J. Alzheimers Dis. 16 (2009) 371-388
3. Caroleo M.C., Costa N., Bracci-Laudiero L., and Aloe L. Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors. J. Neuroimmunol. 113 2 (2001) 193-201
4. Counts S.E., and Mufson E.J. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J. Neuropathol. Exp. Neurol. 64 (2005) 263-272
5. D'Mello C., Le T., and Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor alpha signaling during peripheral organ inflammation. J. Neurosci. 29 (2009) 2089-2102
6. Danielyan L., Schäfer R., von Ameln-Mayerhofer A., Buadze M., Geisler J., Klopfer T., Burkhardt U., Proksch B., Verleysdonk S., Ayturan M., Buniatian G.H., Gleiter C.H., and Frey II W.H. Intranasal delivery of cells to the brain. Eur. J. Cell Biol. 88 (2009) 315-324
7. Deierborg T., Soulet D., Roybon L., Hall V., and Brundin P. Emerging restorative treatments for Parkinson's disease. Prog. Neurobiol. 85 (2008) 407-432
8. Deshmane S.L., Kremlev S., Amini S., and Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29 6 (2009) 313-326
9. Dreyfus C.F. Effects of nerve growth factor on cholinergic brain neurons. Trends Pharmacol. Sci. 10 (1989) 145-149
10. Floris S., Ruuls S.R., Wierinckx A., van der Pol S.M., Dopp E., van der Meide P.H., Dijkstra C.D., and De Vries H.E. Interferon-beta directly influences monocyte infiltration into the central nervous system. J. Neuroimmunol. 127 (2002) 69-79
11. Francis P.T., Palmer A.M., Snape M., and Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66 (1999) 137-147
12. Gähwiler B.H., Capogna M., Debanne D., McKinney R.A., and Thompson S.M. Organotypic slice cultures: a technique has come of age. Trends Neurosci. 10 (1997) 471-477
13. Galimberti D., Fenoglio C., Lovati C., Venturelli E., Guidi I., Corrà B., Scalabrini D., Clerici F., Mariani C., Bresolin N., and Scarpini E. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol. Aging 27 12 (2006) 1763-1768
14. Gehrmann J., Matsumoto Y., and Kreutzberg G.W. Microglia: intrinsic immunoeffector cell of the brain. Brain Res. Rev. 20 (1995) 269-287
15. Giri R., Selvaraj S., Miller C.A., Hofman F., Yan S.D., Stern D., Zlokovic B.V., and Kaalraa V.K. Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. Am. J. Physiol. Cell Physiol. 283 (2002) C895-C904
16. Granholm A.C., Bäckman C., Bloom F., Ebendal T., Gerhardt G.A., Hoffer B., Mackerlova L., Olson L., Söderström S., Walus L.R., and Friden P.M. NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants. J. Pharmacol. Exp. Ther. 268 (1994) 448-459
17. Greenwood J., Etienne-Manneville S., Adamson P., and Couraud P.O. Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul. Pharmacol. 38 (2002) 315-322
18. Gu H., Long D., Song C., and Li X. Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion. Neurosci. Lett. 453 (2009) 204-209
19. Hefti F., and Will B. Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons; implications for Alzheimer's disease. J. Neural Transm. 24 (1987) 309-315
20. Hefti F., Hartikka J., Eckenstein F., Gnahn H., Heumann R., and Schwab M. Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons. Neuroscience 14 (1985) 55-68
21. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11 (1999) 125-137
22. Hölscher C. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Rev. Neurosci. 16 (2005) 181-212
23. Humpel C. Basolateral aggregated rat amyloidβ (1-42) potentiates transmigration of primary rat monocytes through a rat blood-brain barrier. Curr. Neurovasc. Res. 5 (2008) 185-192
24. Humpel C., and Weis C. Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices. Implications in Alzheimer's disease?. J. Neural Transm. 62 (2002) 253-263
25. Ifergan I., Kebir H., Bernard M., Wosik K., Dodelet-Devillers A., Cayrol R., Arbour N., and Prat A. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131 (2008) 785-799
26. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
27. Lapchak P.A. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp. Neurol. 124 (1993) 16-20
28. Leone C., Le Pavec G., Meme W., Porcheray F., Samah B., Dormont D., and Gras G. Characterization of human monocyte-derived microglia-like cells. Glia 54 (2006) 183-192
29. Levi-Montalcini R. The nerve growth factor 35 years later. Science 237 (1987) 1154-1162
30. Mandel R.J., and Burger C. Clinical trails in neurological disorders using AAV vectors: promises and challenges. Curr. Opin. Mol. Ther. 6 (2004) 482-490
31. Marksteiner J., and Humpel C. Beta-amyloid expression, release and extracellular deposition in aged rat brain slices. Molecular Psychiatry, Mol. Psychiatry 13 2008 (2008) 939-952
32. Moser K.V., and Humpel C. Primary rat monocytes migrate through a BCEC-monolayer and express microglia-markers at the basolateral side. Brain Res. Bull. 74 (2007) 336-343
33. Moser K.V., Schmidt-Kastner R., Hinterhuber H., and Humpel C. Brain capillaries and cholinergic neurons persist in organotypic brain slices in the absence of blood flow. Eur. J. Neurosci. 18 (2003) 85-94
34. Moser K.V., Stöckl P., and Humpel C. Cholinergic neurons degenerate when exposed to conditioned medium of primary rat capillary endothelial cells: counteraction by NGF, MK-801 and inflammation. Exp. Gerontol. 41 (2006) 609-618
35. Naumann T., Kermer P., and Frotscher M. Fine structure of rat septohippocampal neurons. III. Recovery of choline acetyltransferase immunoreactivity after fimbria-fornix transection. J. Comp. Neurol. 350 2 (1994 Dec 8) 161-170
36. Naumann T., Peterson G.M., and Frotscher M. Fine structure of rat septohippocampal neurons: II. A time course analysis following axotomy. J. Comp. Neurol. 325 2 (1992 Nov 8) 219-242
37. Olson L., Nordberg A., von Holst H., Bäckman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A., Lundqvist H., Långström B., Meyerson B., Persson A., Viitanen M., Winblad B., and Seiger Å. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient. J. Neural Transm. 4 (1992) 79-95
38. Perriere N., Demeuse P., Garcia E., Regina A., Debray M., Andreux J.-P., Couvreur P., Scherrmann J.-M., Temsamani J., Couraud P.-O., Deli M.A., and Roux F. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J. Neurochem. 93 (2005) 279-289
39. Perry E.K. Nerve growth factor and the basal forebrain cholinergic system: a link in the etiopathology of neurodegenerative dementias?. Alzheimer Dis. Assoc. Disord. 4 (1990) 1-13
40. Perry V.H., Bell M.D., Brown H.C., and Matyszak M.K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5 (1995) 636-641
41. Scherrmann J.M. Drug delivery to brain via the blood-brain barrier. Vas. Pharmacol. 38 (2002) 349-354
42. Schliebs R., and Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J. Neural Trans. 113 (2006) 1625-1644
43. Scriba A., Luciano L., and Steininger B. High-yield purification of rat monocytes by combined density gradient and immunomagnetic separation. J. Immunol. Methods 189 (1996) 203-216
44. Seiger A., Nordberg A., von Holst H., Bäckman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., and Lilja A. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav. Brain Res. 57 (1993) 255-261
45. Slevin J.T., Gerhardt G.A., and Smith C.D. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glia cell-derived neurothrophic factor. J. Neurosurg. 102 (2005) 216-222
46. Stoll G., and Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58 (1999) 233-247
47. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37 (1991) 173-182
48. Tuszynski M.H., and Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Prog Brain Res. 146 (2004) 441-449
49. Tuszynski M.H., Thal L., Pay M., Salmon D.P., U H.S., Bakay R., Patel P., Blesch A., Vahlsing H.L., Ho G., Tong G., Potkin S.G., Fallon J., Hansen L., Mufson E.J., Kordower J.H., Gall C., and Conner J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11 (2005) 551-555
50. van der Zee C.E., and Hagg T. Delayed NGF infusion fails to reverse axotomy-induced degeneration of basal forebrain cholinergic neurons in adult p75(LNTR)-deficient mice. Neuroscience 110 4 (2002) 641-651
51. Van Furth R., and Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128 (1968) 415-435
52. Volkman A. The origin and fate of the monocyte. Ser. Haematol. 3 (1970) 62-92
53. Weis C., Marksteiner J., and Humpel C. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert. Neuroscience 102 (2001) 129-138
54. Wilms H., Hartmann D., and Sievers J. Ramification of microglia, monocytes and macrophages in vitro: influences of various epithelial and mesenchymal cells and their conditioned media. Cell Tissue Res. 287 (1997) 447-458
55. Zassler B., Blasig I., and Humpel C. Protein delivery of caspase-3 induces cell death in malignant C6 glioma, primary astrocytes and immortalized and primary brain capillary endothelial cells. J. Neurooncol. 71 (2005) 127-134
56. Zassler B., Dechant G., and Humpel C. Urea enhances the NGF-induced neuroprotective effect on cholinergic neurons in organotypic rat brain slices. Neuroscience 130 (2005) 317-323
57. Zassler B., and Humpel C. Transplantation of NGF secreting primary monocytes counteracts NMDA-induced cell death of rat cholinergic neurons in vivo. Exp. Neurol. 198 (2006) 391-400
58. Zheng X., Lundberg M., Karlsson A., and Johansson M. Lipid-mediated protein delivery of suicide nucleoside kinases. Cancer Res. 63 (2003) 6909-6913